Efficacy of melatonin treatment in a phase advance model of insomnia
褪黑素治疗失眠阶段进展模型的疗效
基本信息
- 批准号:8288790
- 负责人:
- 金额:$ 31.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:AccidentsAddressAffectAgonistArousalBiological ClocksBody TemperatureCircadian Rhythm Sleep DisordersCircadian RhythmsDelayed Sleep Phase SyndromeDevelopmentDiseaseDoseEvidence based treatmentExposure toEyeFood SupplementsGastrointestinal DiseasesGeneral PopulationHealthHormonesHourHumanHydrocortisoneIndividualJet Lag SyndromeLaboratoriesLeadLightMaintenanceMeasuresMelatoninMeta-AnalysisMethodsModelingNorth AmericaOutcomePathway interactionsPerformancePhasePhase response curvesPhysiologicalPineal glandPlacebosPlasmaPrimary InsomniaProcessPropertyRandomized Controlled TrialsReportingResearch PersonnelSafetyScheduleSimulateSleepSleep DisordersSleep Wake CycleSleeplessnessSupplementationSystemTestingTimeTransient InsomniaTravelUnited StatesVisually Impaired PersonsWakefulnessalertnessawakebasecircadian pacemakercosteffective therapyexperienceheart disease riskimprovedpressureshift worksleep onsetsuprachiasmatic nucleussystematic reviewtreatment duration
项目摘要
Melatonin is a hormone produced by the pineal gland at night. The timing of its release is controlled
by the circadian timing system. Its timing can be suppressed or reset by exposure to light through a
multisynaptic pathway from the eye through the suprachiasmatic nucleus, the master circadian clock.
Exogenous melatonin supplementation has been reported to act in two ways in humans: as a soporific
(sleep-promoting) and a chronobiotic (to reset circadian phase), thus affecting both of the
neurobiologic systems that interact to regulate sleep and wakefulness. Melatonin supplements have
been reported to be an effective treatment for circadian rhythm sleep disorders, including shift work
dyssomnia, jet-lag, delayed sleep phase syndrome, and sleep disruption suffered by many blind
individuals. However, in a recent meta-analysis, the vast majority of these reports were excluded
because they were not randomized controlled trials. The conclusion was that melatonin is not
efficacious for sleep complaints associated with jetlag and shift work. In view of the widespread,
uncontrolled, over-the-counter use of melatonin for treating sleep complaints in the general
population, a randomized controlled trial of melatonin is essential to evaluate efficacy in treatment of
transient insomnia.
The current proposal will test the chronobiotic and sleep promoting effects of melatonin in a phase
advance model of insomnia. Subjects will be administered either melatonin or placebo before a
scheduled sleep episode which is advanced by several hours, simulating eastward travel. Under
these conditions, low sleep pressure and the timing of the circadian clock make sleep particularly
difficult. We will measure sleep and multiple physiologic rhythms controlled by the circadian after
melatonin or placebo administration, and use precise analytic methods to determine the impact of
melatonin on sleep and the human circadian timing system. This study will provide important
information regarding the mechanism of action of melatonin that will be critical for the use of melatonin
as a treatment for circadian rhythm sleep disorders.
褪黑激素是松果体在夜间产生的一种激素。其发布时间受到控制
通过昼夜节律计时系统。它的计时可以通过暴露在光下来抑制或重置
从眼睛到视交叉上核(主生物钟)的多突触通路。
据报道,外源性褪黑激素补充剂对人类有两种作用:
(促进睡眠)和计时生物(重置昼夜节律阶段),从而影响两者
相互作用调节睡眠和觉醒的神经生物学系统。褪黑素补充剂有
据报道,它是治疗昼夜节律睡眠障碍的有效方法,包括轮班工作
许多盲人都患有睡眠障碍、时差反应、睡眠时相延迟综合症和睡眠障碍
个人。然而,在最近的一项荟萃分析中,绝大多数这些报告被排除在外
因为它们不是随机对照试验。结论是褪黑素不
对于与时差和轮班工作相关的睡眠问题有效。鉴于普遍存在的情况,
一般情况下,不受控制地使用非处方褪黑激素来治疗睡眠问题
人群中,褪黑激素的随机对照试验对于评估治疗效果至关重要
短暂性失眠。
目前的提案将分阶段测试褪黑激素的生物钟和促进睡眠的作用
失眠的先进模型。受试者将在试验前服用褪黑激素或安慰剂
预定的睡眠时间提前几个小时,模拟向东旅行。在下面
这些条件、低睡眠压力和生物钟的时间安排使睡眠特别困难
难的。之后我们将测量睡眠和昼夜节律控制的多种生理节律。
褪黑激素或安慰剂给药,并使用精确的分析方法来确定褪黑激素或安慰剂的影响
褪黑激素对睡眠和人体昼夜节律系统的影响。这项研究将提供重要
有关褪黑激素作用机制的信息对于褪黑激素的使用至关重要
作为昼夜节律睡眠障碍的治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Charles A Czeisler其他文献
Charles A Czeisler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Charles A Czeisler', 18)}}的其他基金
Real-time breath metabolomics: A new direction for circadian biomarkers
实时呼吸代谢组学:昼夜节律生物标志物的新方向
- 批准号:
10526014 - 财政年份:2022
- 资助金额:
$ 31.43万 - 项目类别:
Influence of Nocturnal Light Exposure on the Impairment of Glucose Tolerance Induced by Chronic Sleep Restriction
夜间光照对慢性睡眠限制所致糖耐量损害的影响
- 批准号:
10458738 - 财政年份:2021
- 资助金额:
$ 31.43万 - 项目类别:
Influence of Nocturnal Light Exposure on the Impairment of Glucose Tolerance Induced by Chronic Sleep Restriction
夜间光照对慢性睡眠限制所致糖耐量损害的影响
- 批准号:
10297979 - 财政年份:2021
- 资助金额:
$ 31.43万 - 项目类别:
Influence of Nocturnal Light Exposure on the Impairment of Glucose Tolerance Induced by Chronic Sleep Restriction
夜间光照对慢性睡眠限制所致糖耐量损害的影响
- 批准号:
10650324 - 财政年份:2021
- 资助金额:
$ 31.43万 - 项目类别:
Proteomic and Transcriptomic Biomarkers of Circadian Timing
昼夜节律的蛋白质组和转录组生物标志物
- 批准号:
10246289 - 财政年份:2020
- 资助金额:
$ 31.43万 - 项目类别:
Multi-scale modeling of sleep behaviors in social networks
社交网络中睡眠行为的多尺度建模
- 批准号:
8453066 - 财政年份:2013
- 资助金额:
$ 31.43万 - 项目类别:
Recurrent circadian disruption & pancreatic B-cell responsiveness in older peopl
周期性昼夜节律紊乱
- 批准号:
8598130 - 财政年份:2013
- 资助金额:
$ 31.43万 - 项目类别:
Multi-Center Trial of Limiting PGY2&3 Resident Work Hours on Patient Safety-CCC
限制PGY2的多中心试验
- 批准号:
8373472 - 财政年份:2012
- 资助金额:
$ 31.43万 - 项目类别:
Multi-Center Trial of Limiting PGY2&3 Resident Work Hours on Patient Safety-CCC
限制PGY2的多中心试验
- 批准号:
8544488 - 财政年份:2012
- 资助金额:
$ 31.43万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
A comparative evaluation of overdose prevention programs in New York City and Rhode Island
纽约市和罗德岛州药物过量预防计划的比较评估
- 批准号:
10629749 - 财政年份:2023
- 资助金额:
$ 31.43万 - 项目类别:
The impact of extra effort and accumulated fatigue in listeners who wear a cochlear implant
额外努力和累积疲劳对佩戴人工耳蜗的听众的影响
- 批准号:
10677929 - 财政年份:2023
- 资助金额:
$ 31.43万 - 项目类别:
Extending Reach, Accuracy, and Therapeutic Capabilities: A Soft Robot for Peripheral Early-Stage Lung Cancer
扩大范围、准确性和治疗能力:用于周围早期肺癌的软机器人
- 批准号:
10637462 - 财政年份:2023
- 资助金额:
$ 31.43万 - 项目类别:
DSPP Scholar Training at the University of Michigan School of Dentistry
密歇根大学牙科学院 DSPP 学者培训
- 批准号:
10661886 - 财政年份:2023
- 资助金额:
$ 31.43万 - 项目类别:
Cellular Mechanisms of State-Dependent Processing in Visual Cortex
视觉皮层状态相关处理的细胞机制
- 批准号:
10736387 - 财政年份:2023
- 资助金额:
$ 31.43万 - 项目类别: